What is the recommended taper schedule for prednisone (corticosteroid)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Prednisone Tapering Recommendations

The optimal prednisone taper involves gradually reducing the dose to 10 mg/day within 4-8 weeks, then reducing by 1 mg every 4 weeks until discontinuation. 1

General Principles

  • Prednisone tapering should be individualized based on disease activity, laboratory markers, and adverse events 1
  • Single daily dosing is preferred over divided doses except in special situations such as prominent night pain while on low doses (<5 mg daily) 2
  • For courses longer than 3 weeks, tapering is necessary to prevent adrenal insufficiency 1

Specific Tapering Schedules by Initial Dose

For High Initial Doses (>30 mg/day)

  • Reduce dose to 10 mg/day within 4-8 weeks 1
  • Then reduce by 1 mg every 4 weeks until discontinuation 2
  • High doses (>30 mg/day) are strongly discouraged unless absolutely necessary for the specific condition 2

For Medium Initial Doses (10-30 mg/day)

  • Taper by 5 mg every week until reaching 10 mg/day 1
  • Then slow the taper to 2.5 mg/week until reaching 5 mg/day 1
  • Further taper by 1 mg every 4 weeks until discontinuation 2

For Low Doses (<10 mg/day)

  • Taper by 1 mg every 4 weeks 1
  • Alternative approach: Use 1.25 mg decrements with alternate-day schedules (e.g., 10/7.5 mg alternate days) 2

Disease-Specific Recommendations

For Autoimmune Hepatitis

  • For adults: From 20 mg daily, reduce by 5 mg every week until 10 mg/day, then further reduction by 2.5 mg/week until 5 mg daily 2
  • For children: Start with 1-2 mg/kg/day (up to 60 mg/day), taper over 6-8 weeks to 0.1-0.2 mg/kg daily or 5 mg daily 2

For Polymyalgia Rheumatica

  • Initial dose: 12.5-25 mg prednisone equivalent daily 2
  • Initial tapering: Reduce to 10 mg/day within 4-8 weeks 2
  • Maintenance tapering: Reduce by 1 mg every 4 weeks until discontinuation 2

For Immune-Related Adverse Events

  • For grade 2 events: Start with 0.5-1 mg/kg/day until symptoms improve to grade 1 2
  • For grade 3-4 events: Start with 1-2 mg/kg/day until symptoms improve to grade 1 2
  • Then taper over 4-6 weeks 2

Managing Relapse During Tapering

  • Return to the pre-relapse dose if symptoms recur 2
  • Gradually decrease within 4-8 weeks to the dose at which relapse occurred 2
  • Consider adding steroid-sparing agents if multiple relapses occur 2

Special Considerations

For Short-Term Use

  • For acute asthma exacerbations, some evidence suggests that a short course without tapering may be as effective as a tapered course 3, 4
  • However, for most conditions requiring more than 3 weeks of treatment, tapering is necessary to prevent adrenal insufficiency 1

For Rheumatoid Arthritis

  • Low doses (≤10 mg/day) are effective and should be tapered slowly using 1 mg decrements every 2-4 weeks 5
  • Consider divided doses (e.g., 5 mg twice daily) for better control of inflammation 5

Common Pitfalls to Avoid

  • Tapering too quickly, which may lead to disease flare or adrenal insufficiency 1
  • Using high initial doses (>30 mg/day) without clear indication 2
  • Failing to provide calcium (800-1000 mg/day) and vitamin D (400-800 units/day) supplementation during treatment 5
  • Not providing patients with clear instructions about tapering schedule 1

Algorithm for Prednisone Tapering

  1. Determine initial dose based on disease severity and patient factors
  2. For doses >10 mg/day:
    • Reduce by 5 mg every 1-2 weeks until reaching 10 mg/day 1
  3. For doses ≤10 mg/day:
    • Slow taper to 1 mg every 4 weeks 2
    • Or use alternate-day dosing (e.g., 10/7.5 mg) 2
  4. Monitor for disease activity and adverse events throughout taper 1
  5. If relapse occurs:
    • Return to pre-relapse dose 2
    • Once controlled, resume taper more gradually 2

References

Guideline

Prednisone Tapering Recommendations

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Double-blind trial of steroid tapering in acute asthma.

Lancet (London, England), 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.